AZTA
Price
$30.59
Change
-$0.18 (-0.58%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
3.36B
34 days until earnings call
FONR
Price
$14.87
Change
+$0.45 (+3.12%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
131.33M
Interact to see
Advertisement

AZTA vs FONR

Header iconAZTA vs FONR Comparison
Open Charts AZTA vs FONRBanner chart's image
Azenta
Price$30.59
Change-$0.18 (-0.58%)
Volume$31.69K
Capitalization3.36B
Fonar
Price$14.87
Change+$0.45 (+3.12%)
Volume$100
Capitalization131.33M
AZTA vs FONR Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. FONR commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and FONR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (AZTA: $30.58 vs. FONR: $14.72)
Brand notoriety: AZTA and FONR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 557% vs. FONR: 68%
Market capitalization -- AZTA: $3.36B vs. FONR: $131.33M
AZTA [@Medical Specialties] is valued at $3.36B. FONR’s [@Medical Specialties] market capitalization is $131.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileFONR’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • FONR’s FA Score: 0 green, 5 red.
According to our system of comparison, FONR is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while FONR’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 5 bearish.
  • FONR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FONR is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Medical Specialties) experienced а +3.17% price change this week, while FONR (@Medical Specialties) price change was +3.81% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

AZTA is expected to report earnings on Jul 31, 2025.

FONR is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than FONR($131M). FONR YTD gains are higher at: -2.774 vs. AZTA (-38.840). AZTA has higher annual earnings (EBITDA): 57.5M vs. FONR (29.4M). AZTA has more cash in the bank: 984M vs. FONR (53.3M). FONR has less debt than AZTA: FONR (35.8M) vs AZTA (66.5M). AZTA has higher revenues than FONR: AZTA (641M) vs FONR (102M).
AZTAFONRAZTA / FONR
Capitalization3.36B131M2,566%
EBITDA57.5M29.4M196%
Gain YTD-38.840-2.7741,400%
P/E RatioN/A11.06-
Revenue641M102M628%
Total Cash984M53.3M1,846%
Total Debt66.5M35.8M186%
FUNDAMENTALS RATINGS
AZTA vs FONR: Fundamental Ratings
AZTA
FONR
OUTLOOK RATING
1..100
1979
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9184
PRICE GROWTH RATING
1..100
6359
P/E GROWTH RATING
1..100
5837
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FONR's Valuation (62) in the Medical Specialties industry is in the same range as AZTA (75) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's SMR Rating (84) in the Medical Specialties industry is in the same range as AZTA (91) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's Price Growth Rating (59) in the Medical Specialties industry is in the same range as AZTA (63) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

FONR's P/E Growth Rating (37) in the Medical Specialties industry is in the same range as AZTA (58) in the Electronic Production Equipment industry. This means that FONR’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAFONR
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
47%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 29 days ago
54%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 10 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UVALX19.35N/A
N/A
Victory Value
AQGIX11.99N/A
N/A
AQR Global Equity I
RTNCX13.01N/A
N/A
Russell Inv Tax-Managed Intl Eq C
AMIDX13.63N/A
N/A
Amana Developing World Institutional
CCMAX9.86N/A
N/A
Conestoga Mid Cap Institutional

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.62%
IQV - AZTA
63%
Loosely correlated
-0.44%
A - AZTA
62%
Loosely correlated
-0.21%
RVTY - AZTA
62%
Loosely correlated
-0.98%
TMO - AZTA
61%
Loosely correlated
-0.93%
MTD - AZTA
61%
Loosely correlated
-0.73%
More

FONR and

Correlation & Price change

A.I.dvisor tells us that FONR and AZTA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FONR and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FONR
1D Price
Change %
FONR100%
+2.08%
AZTA - FONR
32%
Poorly correlated
-0.62%
IMDX - FONR
30%
Poorly correlated
-5.34%
AVHHL - FONR
30%
Poorly correlated
+24.13%
KIDS - FONR
27%
Poorly correlated
-2.02%
SAUHY - FONR
25%
Poorly correlated
+0.93%
More